Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Context Therapeutics Inc. | 123,500 | reported | 12 Jun 2025 | tx 4+198,500 |
| ESSA Pharma Inc. | 50,000 | reported | 25 Mar 2024 | tx 1+50,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2025 | GRANT_AWARD | Context Therapeutics Inc. | 123,500 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Context Therapeutics Inc. | 25,000 | 0.00 USD | deriv |
| 25 Mar 2024 | GRANT_AWARD | ESSA Pharma Inc. | 50,000 | 0.00 USD | deriv |
| 31 May 2023 | GRANT_AWARD | Context Therapeutics Inc. | 25,000 | 0.00 USD | deriv |
| 02 Jun 2022 | GRANT_AWARD | Context Therapeutics Inc. | 25,000 | 0.00 USD | deriv |